Business Wire

AVEX-MUSIC-CREATIVE

Del
Japanese Singer Namie Amuro Releases World's First Google Chrome Music Video "Anything", off Her 11th Album "_genic", Scheduled for Release on June 10

Japanese singer Namie Amuro and Dimension Point, one of the labels at Avex Music Creative Inc., released the world’s first Google Chrome music video today. The music video is for “Anything”, the first single off of her 11th upcoming 11th album, “_genic”, scheduled for release on June 4, 2015 (Japan Time).

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150604005515/en/

The new music video leverages Google Chrome Extensions to allow viewers to easily enjoy an enhanced version of the video. The Google Chrome version offers a brand new experience, unraveling mysteries in the standard version, and uses windows and tabs to express the music featured in the video. Namie Amuro commented, "I hope everyone enjoys this new visual experience."
http://anything.namieamuro.jp/

About the original version of “Anything” music video
The music video expresses the song’s title, “Anything”. Namie Amuro sings as if she is speaking to the listener, surrounded by scenes that are made dark and somber by an unseen force. In the final scene, she shoulders the prayers of hope from the people, the world is renewed, and the landscape becomes full of light.

The YouTube video is here.
https://www.youtube.com/watch?v=zWkq4FYOdME

About the Google Chrome version of “Anything”
Simply install the Google Chrome Extensions to watch the enhanced version of the “Anything” music video. This is the world’s first music video that uses Google Chrome’s Extensions, and it features a completely new music video experience. This version unravels secrets that were concealed in the standard version, and moves windows and tabs in connection with the music.

In the final scene when Namie Amuro reaches out her right hand, a download begins, giving the user a surprise present only available with the Google Chrome version.

Access negative movie scenes on the special “Anything for Google Chrome” site (http://anything.namieamuro.jp/-----/ ) after watching the video, and experience more tricks that can be viewed with the Google Chrome Extensions.

Customize your Google Chrome home screen
By installing the “Namie Amuro ‘Anything’ for Google Chrome” Extensions, users can also customize their Google Chrome homepage in Namie Amuro style. Every time Google Chrome is opened, and every time a new tab is opened, users can watch a music video from her new album “_genic”. Enjoy a special home screen that’s like a new type of media close at hand.

Background of this Project
Namie Amuro’s creative team was looking for a way to make a new music video, and they created a plan to make it the first music video that uses Google Chrome Extensions.

Google Chrome Extensions
Google Chrome Extensions are functions that can be added to Google Chrome. Users can customize Google Chrome using Extensions. Install the “Namie Amuro ‘Anything’ for Google Chrome” extension to easily watch the Google Chrome version of the “Anything” video.

Avex Group Holdings Inc.
Avex Group Holdings Inc. (Tokyo Stock Exchange: 7860) is a major general entertainment group in Japan. Founded by the CEO and representative director, Masato Matsuura, in 1988. Started the dance music trend in Japan. Currently handles video distribution service, production business, live entertainment as well as music business. Traded 156.9 billion yen in 2013, marking record sales for three years running. Paid video distribution service subscriber base is among the largest in Japan. Shifting Asian business focus to Southeast Asia, established Avex International Holdings Singapore Pte. Ltd. in 2013. Other international offices are in Taiwan as well as in London to manage the classical music label, avex-CLASSICS. For more information, visit http://www.avex.co.jp/e_site/index.html

About Dimension Point
Dimension Point is Namie Amuro’s record label. The label’s first release was Namie Amuro’s album, Feel, which was released on July 10, 2013. Since then, the label has released other recordings by Namie Amuro, as well as a dance compilation album, Twerk ‘em All, which was released in July 2014. Click here for the official label site. http://dimension-point.jp

Contact:

Dentsu Public Relations Inc.
Itaru Kunieda, +81-3-5565-8426
itaru.kunieda@dentsu-pr.co.jp

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release

- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release

With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp

Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release

The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev

7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release

MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t

First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release

Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye